Condition: Non-Alcoholic Fatty Liver Disease · Sponsor: Valbiotis
This clinical trial aims to investigate the effects of TOTUM-448, a mix of 5 plant extracts and choline, consumed at the daily regimen of two times per day, on liver fat content, cardiometabolic risk factors and gut microbiota among both men and women with MASLD.
This description comes directly from the study's public registry record.
Véronique Sapone, MSc · +33 (0)6 75 32 66 59 · veronique.sapone@valbiotis.com
Always discuss trial participation with your own doctor first.
| Institut sur la nutrition et les aliments fonctionnels (INAF) | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06704321